You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
22 January 2026 - NeuroSense Therapeutics Ltd (NASDAQ:NRSN), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, announced on Wednesday that the United States Patent and Trademark Office has ...
22 January 2026 - Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq: ATOS) announced on Wednesday that The Healthcare Technology Report has recognized the company's founder, chairman, president, and chief executive officer...
21 January 2026 - Biopharmaceutical company Avacta Group PLC (AIM: AVCT) announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration of the Investigational New Drug application for FAP-Exatecan (AVA6103), the comp...
21 January 2026 - Danish pharmaceutical company LEO Pharma A/S said on Wednesday that it has initiated the phase 3 DELTA CARE 1 trial to evaluate the efficacy and safety of Anzupgo (delgocitinib) cream versus cream vehicle in adults with mild to seve...
21 January 2026 - Insilico Medicine (HKEX: 3696), a Hong Kong-based clinical-stage biotechnology company that utilises generative artificial intelligence (AI), announced on Tuesday that it has signed a co-development collaboration agreement with Hygt...
21 January 2026 - HistoIndex, a Singapore-based developer of AI-driven digital pathology solutions for chronic liver disease, said on Tuesday that it has formed a strategic partnership with Houston Research Institute (HRI), a US research institute fo...
20 January 2026 - UK biopharmaceutical company GSK plc (LSE/NYSE: GSK) on Tuesday announced a definitive agreement to acquire RAPT Therapeutics (NASDAQ:RAPT), a California-based clinical-stage biopharmaceutical company, in a transaction valued at app...